Latest Share Chat

REMOVE ADS

Hemogenyx Pharmaceuticals Share News (HEMO)

Hemogenyx Pharmaceuticals Information

Share Price Information for Hemogenyx Pharmaceuticals (HEMO)

Share Price is delayed by 15 minutes

Get Live Data

794.00 -35.50 (-4.44%)

Bid:

735.00

Ask:

794.00

Spread: 59.00 (8.027%)

Market Cap: £53.99m

Last checked at -

Intraday Hemogenyx Pharmaceuticals Share Chart

REMOVE ADS

Hemogenyx Pharmaceuticals News

TRADING UPDATES: Safestay mulls asset sale; Sound Energy inks 2 deals

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

TRADING UPDATES: Valereum invests in Blubird; Hemogenyx raises funds

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

UK shareholder meetings calendar - next 7 days

IN BRIEF: Hemogenyx expands trial to include paediatric patients

Hemogenyx Pharmaceuticals PLC - London-headquartered biopharmaceutical company focused on treatments for blood diseases - Says it has filed, with the ...

TRADING UPDATES: GlobalData suspends buyback; Hemogenyx trial progress

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

TRADING UPDATES: Golden Rock secures refinancing; tinyBuild makes sale

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

IN BRIEF: Hemogenyx administers first human dose for leukemia therapy

Hemogenyx Pharmaceuticals PLC - London-based biotechnology company - Administers its first in-human dose of HG-CT-1, the firm's proprietary CAR-T cell...

IN BRIEF: Hemogenyx Pharmaceuticals raises GBP340,000 for drug trial

Hemogenyx Pharmaceuticals PLC - London-based biotechnology company - Says it has raised GBP340,000 through the placing of 100,000 shares at 340p each....